Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BIT/1ABBV stock hub

BIT/1ABBV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BIT/1ABBVis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
302.5B
Borsa Italiana
Market data

Live price

Current market quote for this ticker.

Current price
BIT/1ABBV
In the news

Latest news · BIT/1ABBV

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5
P25 n/aP50 n/aP75 n/a
Trailing P/E97
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC22.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BIT/1ABBV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
191
Groups with data
11
Currency
USD
Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
IT
Employees
57,000
Employees Change
2,000%
Employees Change Percent
3.64
Enterprise value
EUR 356.5B
Exchange
Borsa Italiana
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 302.5B
Price
EUR 171
Price currency
EUR
Rev Per Employee
955,840.68x
Sic
2836
Symbol
bit/1ABBV
Website
https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
1.03%
EV Earnings
114.35x
EV/EBIT
19.18x
EV/EBITDA
13.85x
EV/FCF
20.58x
EV/Sales
6.68x
FCF yield
5.73%
Forward P/E
13.5x
P/B ratio
-52.76x
P/E ratio
97.03x
P/S ratio
5.55x
PE Ratio10 Y
39.99x
PE Ratio3 Y
77.83x
PE Ratio5 Y
56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
34.83%
EBITDA Margin
47.62%
FCF margin
31.81%
Gross margin
72.03%
Gross Profit
EUR 39.2B
Gross Profit Growth
11.06%
Gross Profit Growth Q
15.45%
Gross Profit Growth3 Y
3.97%
Gross Profit Growth5 Y
5.95%
Net Income
EUR 3.1B
Net Income Growth
-13.35%
Net Income Growth Q
-45.96%
Net Income Growth3 Y
-21.86%
Net Income Growth5 Y
-6.73%
Pretax Margin
9.51%
Profit Margin
5.79%
Profit Per Employee
EUR 54,701
ROA
10.03
Roa5y
8.68
ROCE
23.19
Roe5y
1,295.2
ROIC
22.24
Roic5y
22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
6.02%
Cagr3y
11.75%
Cagr5y
16.54%
Div CAGR3
1.22%
Div CAGR5
6.59%
EPS Growth
-13.24
EPS Growth Q
-45.83
EPS Growth3 Y
-21.78
EPS Growth5 Y
-6.98
Revenue Growth
9.5x
Revenue Growth Q
12.43x
Revenue Growth3 Y
3.45x
Revenue Growth5 Y
4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Asset Turnover
EUR 0.46
Assets
EUR 118.4B
Cash
EUR 8.1B
Debt
EUR 63.2B
Debt EBITDA
EUR 2.41
Debt FCF
EUR 3.65
Equity
EUR -5.7B
Interest Coverage
7.52
Liabilities
EUR 124.1B
Net Cash
EUR -55.1B
Net Cash By Market Cap
EUR -18.21
Net Debt EBITDA
EUR 2.12
Net Debt FCF
EUR 3.18
Tangible Book Value
EUR -80.7B
Tangible Book Value Per Share
EUR -45.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.8
Inventory Turnover
3.67
Net Working Capital
EUR -8.3B
Quick ratio
0.52
Working Capital
EUR -7.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.04%
Dividend Growth
34.8%
Dividend Growth Years
0%
Dividend per share
EUR 5.78
Dividend Years
8
Dividend Yield
3.38%
Ex Div Date
2026-04-14
Last Dividend
EUR 1.48
Payout Frequency
Quarterly
Payout Ratio
325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
6.02%
200-day SMA
186.7
3Y total return
39.56%
50-day SMA
182.7
50-day SMA vs 200-day SMA
50under200
5Y total return
114.95%
All Time High
208
All Time High Change
-17.86%
All Time High Date
2025-10-06
All Time Low
60.4
All Time Low Change
182.86%
All Time Low Date
2020-03-23
ATR
2.97
Ch YTD
-12.47
High52
208
High52 Date
2025-10-06
High52ch
-17.86%
Low52
151.6
Low52 Date
2025-07-14
Low52ch
12.7%
Ma50ch
-6.49%
Price vs 200-day SMA
-8.47%
RSI
42.55
RSI Monthly
48.34
RSI Weekly
38.33
Sharpe ratio
0.28x
Sortino ratio
0.6
Total Return
3.34%
Tr YTD
-11.03
Tr1m
-1.37%
Tr1w
-3.47%
Tr3m
-9.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 19B
Operating Income Growth
15
Operating Income Growth Q
16.6
Operating Income Growth3 Y
0.7
Operating Income Growth5 Y
5.78
Operating margin
34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,763,680,450%
Shares Insiders
0.07%
Shares Institutions
76.02%
Shares Qo Q
0%
Shares Yo Y
0.04%
Short Ratio
3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
EUR 16.5B
Average Volume
25.85x
Bv Per Share
-3.27
CAPEX
EUR -1.1B
Ch1m
-2.2
Ch1w
-3.47
Ch1y
2.67
Ch3m
-9.89
Ch3y
26.46
Ch5y
79.8
Ch6m
-9.6
Change
-1.13%
Close
172.8
Depreciation Amortization
6,897,958,879.5
Earnings Date
2026-04-29
EBIT
EUR 19B
EBITDA
EUR 25.9B
EPS
EUR 1.76
F Score
7
FCF
EUR 17.3B
FCF EV Yield
4.86x
Financing CF
-9,147,413,100
Fiscal Year End
December
Founded
2,012
Income Tax
EUR 2B
Investing CF
-5,621,838,600
Is Primary Listing
0
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Lynch Fair Value
EUR 8.8
Lynch Upside
-94.85
Ma150
189.7
Ma150ch
-9.95%
Ma20
173.9
Ma20ch
-1.78%
Net CF
3,656,536,800
P FCF Ratio
17.46
P OCF Ratio
16.44
Payment Date
2026-05-15
Price Date
2026-05-08
Price EBITDA
EUR 11.66
Relative Volume
0.38x
Revenue
54,482,918,700x
SBC By Revenue
1.57x
Share Based Comp
857,759,700
Tax By Revenue
3.72x
Tax Rate
39.06%
Tr6m
-8.11%
Z Score
2.29
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BIT/1ABBV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.4%
$5.78 annual per share
Payout ratio
+325.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+6.6%
0 consecutive years of growth
Total shareholder yield
+3.3%
Next ex-dividend date: 2026-04-14
Performance

BIT/1ABBV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+6.0%
S&P 500 1Y: n/a
3Y total return
+39.6%
S&P 500 3Y: n/a
5Y total return
+114.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BIT/1ABBV?

Insider, institutional, and short-interest positioning.

Institutional ownership
+76.0%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.2 days to cover
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

BIT/1ABBV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.5
Neutral momentum band
Price vs 200-day MA
-8.5%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.28
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BIT/1ABBV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1ABBV stock rating?

bit/1ABBV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1ABBV analysis?

The full report lives at /stocks/bit/1ABBV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1ABBV?

The latest report frames bit/1ABBV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1ABBV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.